SOURCE: Industrial Info Resources

Industrial Info Resources

February 29, 2012 06:40 ET

Pharma-Biotech Capital Construction Investment Snapshot: 2012 North American Project Starts Top $16 Billion, an Industrial Info News Alert

SUGAR LAND, TX--(Marketwire - Feb 29, 2012) - Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- Barely two months into the new year, it is time to buckle up and enjoy the wild ride known as the Pharmaceutical-Biotech Industry. In January 2012, the industry as a whole had more than $17 billion in capital and maintenance projects scheduled to kick off this year. A scant month later, that total has dropped to slightly more than $16 billion. Thanks in no small part to the Obama administration's financial decisions, $695 million destined for the National Bio and Agro-Defense facility in Manhattan, Kansas, has been pushed out of 2012, as its budget is reworked.

Companies featured: Gilead Sciences Incorporated (NASDAQ:GILD), Novartis AG (NYSE:NVS)

For details, view the entire article by subscribing to Industrial Info's Premium Industry News at, or browse other breaking industrial news stories at

Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, and eight offices outside of North America, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the "Contact Us" page.

Contact Information

  • Contact:
    Joe Govreau